Abstract
А series of novel 6,6,7-trisubstituted thiopyrano[2,3-d][1,3]thiazoles-based molecules have been synthesized and evaluated as potential antitrypanosomal agents. The most active analogue 3b inhibited Trypanosoma brucei brucei and Trypanosoma brucei gambiense with an IC(50) of 0.26 and 0.42 μМ, respectively. They could be considered as potent hits for further antitrypanosomal drug discovery efforts.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Humans
-
Pyrans / chemistry*
-
Pyrrolidines / chemical synthesis
-
Pyrrolidines / chemistry
-
Pyrrolidines / pharmacology
-
Sulfhydryl Compounds / chemistry*
-
Thiazoles / chemical synthesis
-
Thiazoles / chemistry*
-
Thiazoles / pharmacology
-
Trypanocidal Agents / chemical synthesis*
-
Trypanocidal Agents / chemistry
-
Trypanocidal Agents / pharmacology
-
Trypanosoma brucei brucei / drug effects
-
Trypanosoma brucei gambiense / drug effects
Substances
-
Pyrans
-
Pyrrolidines
-
Sulfhydryl Compounds
-
Thiazoles
-
Trypanocidal Agents
-
rel-(6'R,7'R)-7'-(3,4-dimethoxyphenyl)-1-(4-chlorophenyl)-3',7'-dihydro-2H,2'H,5H-spiro(pyrolidin-3,6'-thiopyrano(2,3-d)thiazol)-2,2',5-trione
-
thiopyran